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ABSTRACT
Background COVID-19 may have a profound impact 
on sexual health, reproductive health and social life 
across the world. Shelter in place regulations that have 
extended across the globe may influence condomless 
sex, exacerbate intimate partner violence and reduce 
access to essential reproductive health services. 
Population representative research is challenging during 
shelter in place, leaving major gaps in our understanding 
of sexual and reproductive health during COVID-19. This 
International Sexual Health And ReproductivE health 
(I- SHARE) study protocol manuscript describes a common 
plan for online national surveys and global comparative 
analyses.
Methods The purpose of this cross- sectional study is 
to better understand sexual and reproductive health in 
selected countries during the COVID-19 pandemic and 
facilitate multinational comparisons. Participants will 
be recruited through an online survey link disseminated 
through local, regional and national networks. In 
each country, a lead organisation will be responsible 
for organising ethical review, translation and survey 
administration. The consortium network provides support 
for national studies, coordination and multinational 
comparison. We will use multilevel modelling to 
determine the relationship between COVID-19 and 
condomless sex, intimate partner violence, access to 
reproductive health services, HIV testing and other key 
items. This study protocol defines primary outcomes, 
prespecified subanalyses and analysis plans.
Conclusion The I- SHARE study examines sexual and 
reproductive health at the national and global level 
during the COVID-19 pandemic. We will use multilevel 
modelling to investigate country- level variables 
associated with outcomes of interest. This will provide 
a foundation for subsequent online multicountry 
comparison using more robust sampling methodologies.
INTRODUCTION
The global COVID-19 pandemic has ushered in 
restrictive social measures that are important for 
its control. However, shelter in place, self- isolation, 
quarantine and cordon sanitaire measures could 
each have a profound influence on sexual and 
reproductive health. For example, COVID-19 
measures may decrease the number of pregnant 
women delivering in hospitals,1 delay care- seeking2 
and increase intimate partner violence.3 Restrictions 
in movement, social isolation and increased social 
and economic pressures will likely increase the risk 
of intimate partner violence in the COVID-19 era.3 
Evidence from other public health emergencies 
(eg, infectious disease epidemics, wars and human-
itarian disasters)4–6 suggests that many women 
are unable to obtain family planning services in 
order to avoid unwanted pregnancies. The Gutt-
macher Institute has noted that several countries 
have reduced or stopped provision of sexual and 
reproductive health services due to COVID-19, 
interrupting supply chains for condoms and other 
contraceptives.7 8 Women who do become pregnant 
during this period may be at greater risk of adverse 
outcomes, including stillbirth, spontaneous abor-
tion (miscarriage) and small for gestational age.9 
In addition, the reorientation of health systems 
towards COVID-19 will have unintended conse-
quences for other health services.2 For example, 
the 2014–2015 Ebola epidemic reduced access 
to healthcare services and may have exacerbated 
HIV mortality rates in Guinea, Liberia and Sierra 
Leone.10
COVID-19 also creates unique challenges for 
population- based behavioural research.11 Many 
research institutes are closed, and both national 
and international travels are restricted. While some 
single- country studies of COVID-19 focused on 
sexual and reproductive health have been organ-
ised, none have been coordinated in a way that 
allows for multicountry analyses. Multicountry 
analyses are important for the following reasons: 
single- country studies are unable to provide insight 
about regional and higher level trends in sexual 
and reproductive health; country- level variation in 
shelter in place policies between countries can be 
empirically examined; and multicountry data allow 
an examination of whether cross- national varia-
tion in sexual and reproductive health results from 
differences in the composition of the populations 
or from differences in the context (eg, COVID-19 
measures).
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Responding to this gap in the literature, our team designed 
an online, multicountry sexual and reproductive health research 
study. This study is part of a project called the International Sexual 
Health And REproductive Health in the times of COVID-19 
(I- SHARE). The purpose of this open science project is to bring 
together a diverse group of sexual health researchers in order 
to harmonise sexual and reproductive health survey instruments 
and faciliate global comparison. The project includes interdisci-
plinary working groups focused on coordination, data analysis, 
survey development, digital technology and survey promotion. 
The I- SHARE project will allow us to examine whether measures 
implemented by the government will heave an effect on sexual 
health outcomes above and beyond individual characteristics. 
This study protocol manuscript describes a common plan for 
online national surveys and global comparative analyses.
METHODS
Goal and aims
The overall goal of this global study is to better understand sexual 
and reproductive health among adults during the COVID-19 
pandemic using an online convenience sample from selected 
countries. The primary study aims are :
1. To examine changes in sexual risk behaviours (especially 
condomless sex) related to the initiation and resolution of 
COVID-19 measures using a multicountry analysis.
2. To examine changes in intimate partner violence related to 
the initiation and resolution of COVID-19 measures using a 
multicountry analysis.
3. To examine changes in access to essential reproductive 
health commodities and services (eg, contraceptives and 
abortion services) related to the initiation and resolution of 
COVID-19 measures using a multicountry analysis.
Secondary study aims include the following:
1. To examine changes in HIV/STI testing related to the initi-
ation and resolution of COVID-19 measures using a multi-
country analysis.
2. To examine changes in harmful cultural practices (eg, female 
genital mutilation and child marriage) related to the initia-
tion and resolution of COVID-19 measures using a multi-
country analysis.
3. To examine changes in mental health and other optional 
secondary outcomes (eg, nutritition) related to the initiation 
and resolution of COVID-19 measures using a multicountry 
analysis.
We will use a cross- sectional online survey with convenience 
sampling in each country. National sample sizes will be calcu-
lated based on national priorities and analyses.
Our collaborative research team brings together two groups: 
the Academic Network for Sexual and Reproductive Health 
and Rights Policy (ANSER) led by the University of Ghent and 
partner institutions; and a team within the London School of 
Hygiene & Tropical Medicine who worked in partnership with 
the Human Reproduction Programme at the World Health
Organisation to develop a standardised sexual health survey 
instrument for use in diverse global settings. Investigators in the 
following countries are piloting online surveys in their respec-
tive countries: Armenia, Argentina, Australia, Botswana, Cezch 
Republic, Canada, China, Colombia, Denmark, Ecuador, Egypt, 
Ethiopia, France, Germany, Italy, Kenya, Latvia, Lebanon, 
Luxembourg, Malaysia, Mexico, Moldova, Mozambique, 
Nigeria, Panama, Portugal, Republic of Moldova, Singapore, 
South Africa, Spain, Sweden, Uganda, Uruguay and the USA. A 
full list of research institutes is available online.12 The in- country 
lead in each country will have first access to national data and 
make final decisions about data sharing. Each in- country lead 
will make preparations for dissemination. The survey link will 
be available for between 2 and 4 weeks. People from outside of 
selected countries will be excluded.
Survey development
The survey instrument has the following sections: sociode-
mographics; compliance with COVID-19 social distancing 
measures; couple and family relationships; sexual behaviour; 
access to contraceptives; access to maternal healthcare; abor-
tion; sexual and intimate partner violence; HIV/STI female 
genital mutilation/cutting and early/forced marriage (optional 
domain); mental health (optional domain); and nutrition 
(optional domain).
In each country, the lead organisation will select networks 
through which to disseminate the link to the survey. The survey 
link will be distributed through email listservs, local partner 
organisations affiliated with ANSER, other sexual and repro-
ductive health networks and social media links. Final decisions 
about incentives will be made by the in- country lead, and the 
survey will take approximately 15–20 min to complete.
The survey development was a collaborative effort of all part-
ners in the project and was partly based on existing questions and 
scales and partly on newly developed questions. The full survey 
instrument is included as online supplemental 1. The network 
will centrally programme the online survey questionnaire using 
Open Data Kit software (V.1.16). This will be an online survey 
self- administered through smartphones, tablets or computers.
In each country, the in- country lead will organise translation, 
local field testing and ethical review. Translation will ensure that 
the survey is available in the national language of the country 
and other relevant languages. Field testing will provide the 
survey instrument in a print form to at least 10 individuals and 
have them provide feedback about translations, covering sensi-
tive topics and preambles. Further field testing in digital form 
among 5–10 potential participants per country will be used to 
iteratively examine errors in skip logic. We estimate between 1 
and 4 rounds of iteration per country survey to finalise content. 
We anticipate that paper- based field testing will finalise the core 
survey instrument structure and digital field testing will finalise 
each country survey instrument. Details of the digital field testing 
are available as online supplemental material.
Inclusion criteria for the survey include 18 years or older (or 
younger if country IRBs and ethical regulations permit and the 
in- country lead can ensure appropriate procedures), currently 
residing in one of the participating countries, and able to provide 
online informed consent. We will include standard fraud protec-
tion methods, including CAPTCHA and measure to prevent 
more than one response from a single IP address (in countries 
where this is available).
Safety considerations
This research study will present no greater than minimal risk to 
participants. At the same time, this survey will include several 
questions that are sensitive in many local settings, including 
questions about sexuality, sexual behaviour, abortion, and inti-
mate partner violence. The participant will be allowed to stop 
the survey at any point and leave out questions that they do 
not wish to answer. We will not collect participant names or 
any other identifiers. Country- level data will only be able to be 
accessed by in- country leaders who have final decisions about 
use of data. Data sharing agreements will be signed between 
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participating country institutions for cross- country analyses. 
National resources for intimate partner violence, sexual health 
services and reproductive health services will be provided at the 
end of the survey.
Data analysis plan
This statistical analysis plan focuses on the multicountry compar-
ison component of the analysis. Only survey data that meet the 
following criteria will be included in the multicountry compar-
ison: at least 200 participants, Institutional Review Board (IRB) 
approval from the local authority, description of sampling meth-
odology, local instrument translated and field tested.
Primary analysis
Sociodemographics will be summarised using descriptive statis-
tics. The multicountry analysis will use multilevel modelling to 
examine individual- level and country- level variables associated 
with primary outcomes, including sexual behaviours, intimate 
partner violence and access to reproductive health services. 
Primary outcomes are further specified in online supplemental 
material. We will use MlwiN 3.05, a software program used in 
multilevel modelling (http://www. cmm. bristol. ac. uk/ MLwiN/). 
The general form of the two- level random intercepts model used 
to predict the proportion of participants with condomless sex 
(specific aim #1) will be of the form:
 logit(πi) = log[πi/(1− πi)] = β0j + β1xij β0j = β0 + u0j. 
This is a binomial logistic multilevel model with random inter-
cepts, and the binary response yij equals 1 if the individual i 
in country j had condomless sex. There is a single explanatory 
variable in this example, xij. The intercept consists of a fixed 
component β0 and a country- specific component, the random 
effect u0j. Similar models will be created to estimate intimate 
partner violence and access to reproductive health services. Data 
on country- level indicators will be collected from the WHO 
and publicly available databases.13 Several of our country- level 
data come from the Oxford COVID-19 Government Response 
Tracker (OxCGRT), an open access database with detailed data 
on 17 COVID-19 indicators in 180 countries.14 The OxCGRT 
has created several indices derived from 17 indicators and report 
a number between 1 and 100 to reflect the level of government 
action. We will focus on the following country- level factors: 
overall government response (OxCGRT), containment and 
health index (OxCGRT), economic support index (OxCGRT), 
stringency of lockdown index (OxCGRT), number of COVID-19 
per 100 000 population, public insurance and estimated exces-
sive mortality when compared with the year prior.
When level 2 sample size is insufficient (eg, female genital 
mutilation and early marriage) to perform a multilevel analysis, 
cross- country differences will be determined through a fixed 
effects model with country as a covariate.
Given that online sampling has its own inherent biases,15 we 
will use propensity score matching in some cases. Propensity 
score methods can be used to reduce coverage error and make 
web survey samples more closely approximate population repre-
sentative samples.16 17 Propensity score methods have been used 
to make groups more comparable based on covariarates.18 Given 
that we also cannot randomly assign study participants to the 
stringency of lockdown measures, a key covariate, propensity 
score methods can help us to make more accurate estimation of 
the associations between COVID-19 and our primary outcomes. 
We will also provide more detailed descriptions of the specific 
country context and COVID-19 response where appropriate.
Subgroup analyses
We will combine data from different countries in order to 
conduct subanalyses on the following groups of individuals: 
people living with HIV infection, pregnant women, younger 
individuals (under 25 years old), individuals under 18 years old 
(if possible), people living in low- income countries compred 
with people in middle- income or high- income countries, people 
living in middle- income countries and people who report an 
income below the median in their country, rural people versus 
urban people, single people compared with not single people, 
sex, and socioeconomic status.
Quality assurance
In- country survey leads will be responsible for quality assurance 
mechanisms. All data collected will be stored on a password- 
protected secure server. Encryption keys will be given to the 
in- country leads so that each country’s data will only be available 
to the in- country lead and people that they designate. Among 
countries willing to share their data for multicountry compari-
sons, deidentified and unlinkable data for multicountry compar-
isons will be stored at the University of Ghent and the University 
of North Carolina at Chapel Hill.
Dissemination of results
Results will be disseminated in scientific papers and also made 
available to a public audience. All participating countries will be 
encouraged to develop a policy brief and communicate research 
findings to relevant policy makers. The ANSER consortium will 
take a lead in providing policy briefs for selected countries.
Project management
General coordination of the multi- country study will be organ-
ised by researchers at the ANSER consortium represented by 
Ghent University and the University of North Carolina at Chapel 
Hill. There are international working groups on: survey devel-
opment, technical support, survey implementation and statistical 
analyses. In each participating country, there will be one lead 
institution responsible for the implementation of the study. The 
network has agreed on a single data management plan (online 
supplemental file 4).
Ethics
In each country where the study will be implemented, the 
local partner will request approval of the appropriate ethical 
committee or review board. Before starting the survey, each 
participant will be asked to read an informed consent form 
(online supplemental material 1) and provide consent through 
checking a box. The informed consent form will include a link to 
more detailed information on privacy regulations and manage-
ment of data. At the end of the survey, the participants will be 
informed about country- specific organisations where they can 
seek help.
DISCUSSION
This multicountry behavioural survey will examine sexual risk 
behaviours, intimate partner violence and access to reproduc-
tive health services during the COVID-19 era. Several structural 
factors increase the importance of understanding sexual and 
reproductive health during this period of time. The I- SHARE 
study breaks new ground by focusing on sexual and reproduc-
tive health during COVID-19, including a range of low- income, 
middle- income and high- income countries, and extending out of 
two complementary global networks (ANSER and the response 
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to a WHO open call). The prespecified subanalyses and analyt-
ical plans outlined here will increase the rigour of this research.
COVID-19 has led to unprecedented uncertainty in our social 
world, with important implications for sexual and reproductive 
health. The pandemic presents unique opportunities and chal-
lenge. Some have hypothesised that social restriction measures 
and decreased travel would decrease the frequency of sexual 
behaviours. In this light, expanded HIV elimination efforts 
related to HIV self- testing and digital interventions could work 
towards eliminating HIV transmission in ways that would have 
been impossible only a few months ago. However, social restric-
tion measures may also decrease access to HIV testing (among 
those without HIV) and ART medication (among people living 
with HIV). Conventional sexual health services, especially those 
focused on intimate partner violence, may be entirely closed or 
operating at limited capacity.19 20
This study has several limitations. First, the cross- sectional 
study will be a convenience sample that precludes causal infer-
ences and necessitates caution when making inferences. Second, 
the online nature of the survey will exclude individuals who do 
not have internet access. Studies have shown that people with 
lower incomes and education are less likely to have internet 
access.21 22 Although there is persistent spatial variation in the 
digital divide,23 there is also a growing literature on how to 
address online sampling bias.24 25 Third, COVID-19 control 
measures differ from country to country. However, there are 
several policy observatory databases that provide detailed open 
access information about specific COVID-19 control measures in 
countries.14 26 27 Fourth, as a cross- national survey, harmonising 
survey questions and responses is not simple. The I- SHARE 
team benefited from a previous series of Human Reproduc-
tion Programme (HRP) consultations to harmonise a sexual 
and reproductive health survey instrument,28 the literature on 
creating cross- national surveys29 and local (national level) exper-
tise in sexual and reproductive health from all included coun-
tries. Fifth, the extent of field testing was dependent on local 
personnel and varied from country to country. Finally, studies 
will gather limited information about adolescents and no infor-
mation about children.
Our study will generate important research and policy impli-
cations. The study outcomes will help guide policy and research 
related to sexual and reproductive health during emergencies 
in the selected countries to improve preparedness for future 
epidemics and disasters. The subgroup analyses will provide 
insights on need, access and equity issues in sexual and repro-
ductive health during a pandemic. Several additional recommen-
dations for sexual and reproductive health survey research are 
included as supplementary material (online supplemental 5). 
Multicountry analyses will provide preliminary data on the asso-
ciation of COVID-19 response with key sexual and reproductive 
health outcomes, paving the way for future research.
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Key messages
 ► Sexual and reproductive health research in the COVID-19 
era is essential, but population- based household sampling 
methods are constrained because of COVID-19 measures.
 ► This International Sexual Health And ReproductivE health 
study protocol describes a cross- sectional online study to 
better understand sexual and reproductive health in selected 
countries during the COVID-19 pandemic and facilitate 
multinational comparisons.
 ► Global research studies, especially in low- income and middle- 
income countries, are necessary to understand how COVID-19 
measures may influence factors such as condomless sex, 
access to reproductive health services and intimate partner 
violence.
 ► Further multicountry research may be helpful for enhancing 
sexual and reproductive health research during COVID-19 
measures.
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